Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$80.93 - $108.63 $48,558 - $65,178
600 Added 9.38%
7,000 $724,000
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $129,096 - $164,646
1,800 Added 39.13%
6,400 $565,000
Q2 2021

Aug 17, 2021

BUY
$75.51 - $84.79 $143,469 - $161,101
1,900 Added 70.37%
4,600 $384,000
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $143,469 - $161,101
-1,900 Reduced 41.3%
2,700 $1.29 Million
Q4 2020

Feb 08, 2021

BUY
$72.61 - $90.2 $334,006 - $414,920
4,600 New
4,600 $403,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Waycross Partners, LLC Portfolio

Follow Waycross Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.